Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
CONCLUSIONS: TAS selectively reduced the tumor load in the axilla and remained much less radical than ALND.PMID:34555676 | DOI:10.1016/j.breast.2021.09.004
Source: Breast - Category: Cancer & Oncology Authors: Walter P Weber Zoltan Matrai Stefanie Hayoz Christoph Tausch Guido Henke Daniel R Zwahlen G ünther Gruber Frank Zimmermann Stefanie Seiler Charlotte Maddox Thomas Ruhstaller Simone Muenst Markus Ackerknecht Sherko Kuemmel Vesna Bjelic-Radisic Christian K Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study